Poolbeg Pharma (LON:POLB) Reaches New 1-Year Low – What’s Next?

Shares of Poolbeg Pharma PLC (LON:POLB) hit a new 52-week low during trading on Tuesday . The company traded as low as GBX 2.70 ($0.03) and last traded at GBX 2.70 ($0.03), with a volume of 1791365 shares. The stock had previously closed at GBX 2.90 ($0.04).

Wall Street Analyst Weigh In

Separately, Shore Capital reaffirmed a “house stock” rating on shares of Poolbeg Pharma in a research report on Thursday, January 2nd.

Poolbeg Pharma Stock Performance

The company has a market capitalization of £13.88 million, a PE ratio of 0.00 and a beta of 2.11. The company has a 50 day moving average price of GBX 4.65 and a 200 day moving average price of GBX 7.33.

Poolbeg Pharma Company Profile

Poolbeg Pharma plc is focussed on the development and commercialisation of innovative medicines targeting serious diseases with a high unmet medical need. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to support the growth of the Company and the development of its robust pipeline of innovative products, thereby driving significant value creation.

Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value.